Gene · 580
Papers4,139
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
861 to 880 of 4,139
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clonal somatic copy number altered driver events inform drug sensitivity in high-grade serous ovarian cancer. | Nat Commun | 2022 | 36289203 | PubTator, text mining | PubMed |
| Prognostic Role of DNA Damage Response Genes Mutations and their Association With the Sensitivity of Olaparib in Prostate Cancer Patients. | Cancer Control | 2022 | 36283420 | PubTator, text mining | PubMed |
| Clinical and molecular characteristics of ARIEL3 patients who derived exceptional benefit from rucaparib maintenance treatment for high-grade ovarian carcinoma. | Gynecol Oncol | 2022 | 36273926 | PubTator, text mining | PubMed |
| Expression of Karyopherin Alpha 2 and Karyopherin Beta 1 Correlate with Poor Prognosis in Gastric Cancer. | Oncology | 2022 | 36273446 | PubTator, text mining | PubMed |
| PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients. | Breast Cancer Res | 2022 | 36271417 | PubTator, text mining | PubMed |
| Li-Fraumeni Syndrome: A Rare Genetic Disorder. | Cureus | 2022 | 36262946 | PubTator, text mining | PubMed |
| A phase II study of talazoparib monotherapy in patients with wild-type BRCA1 and BRCA2 with a mutation in other homologous recombination genes. | Nat Cancer | 2022 | 36253484 | PubTator, text mining | PubMed |
| Establishment and verification of a prognostic model of liver cancer by RNA-binding proteins based on the TCGA database. | Transl Cancer Res | 2022 | 36249884 | PubTator, text mining | PubMed |
| Editorial: Mechanistic studies of genome integrity, environmental health, and cancer etiology. | Front Cell Dev Biol | 2022 | 36247007 | PubTator, text mining | PubMed |
| Gene-specific machine learning model to predict the pathogenicity of BRCA2 variants. | Front Genet | 2022 | 36246618 | PubTator, text mining | PubMed |
| Molecular Biomarkers for the Early Detection of Ovarian Cancer. | Int J Mol Sci | 2022 | 36233339 | PubTator, text mining | PubMed |
| Moderate-Risk Genes for Hereditary Ovarian Cancers Involved in the Homologous Recombination Repair Pathway. | Int J Mol Sci | 2022 | 36233090 | PubTator, text mining | PubMed |
| Association of Common Variants in OLA1 Gene with Preclinical Atherosclerosis. | Int J Mol Sci | 2022 | 36232807 | PubTator, text mining | PubMed |
| Organoids: A New Chapter in Sarcoma Diagnosis and Treatment. | Int J Mol Sci | 2022 | 36232574 | PubTator, text mining | PubMed |
| Germline Variants in 32 Cancer-Related Genes among 700 Chinese Breast Cancer Patients by Next-Generation Sequencing: A Clinic-Based, Observational Study. | Int J Mol Sci | 2022 | 36232564 | PubTator, text mining | PubMed |
| Hereditary Ovarian Cancer: Towards a Cost-Effective Prevention Strategy. | Int J Environ Res Public Health | 2022 | 36231355 | PubTator, text mining | PubMed |
| PARP Inhibitors in Advanced Prostate Cancer in Tumors with DNA Damage Signatures. | Cancers (Basel) | 2022 | 36230674 | PubTator, text mining | PubMed |
| A Large Case-Control Study Performed in Spanish Population Suggests That RECQL5 Is the Only RECQ Helicase Involved in Breast Cancer Susceptibility. | Cancers (Basel) | 2022 | 36230663 | PubTator, text mining | PubMed |
| Transcriptional regulation and chromatin dynamics at DNA double-strand breaks. | Exp Mol Med | 2022 | 36229590 | PubTator, text mining | PubMed |
| MED1, a novel binding partner of BRCA1, regulates homologous recombination and R-loop processing. | Sci Rep | 2022 | 36229463 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/580/papers?page=44